Articles tagged "Allocation"

2021 American Transplant Congress
Geographic Divergence in Waitlist Registration and Trends in Waitlist Removal for Liver Transplantation in Patients with Nonalcoholic Steatohepatitis (NASH)
C. Hanlon¹, B. Saberi², L. Yuan¹
¹Internal Medicine - Transplant Hepatology, University of Southern California, Los Angeles, CA, ²Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, MA
*Purpose: This study aims to evaluate regional trends of waitlist (WL) registrations and removal for liver transplantation (LT) among United States (US) adults listed for…
2021 American Transplant Congress
Accounting for Survivor Bias in Transplant Benefit Models
E. M. Schnellinger¹, E. Cantu², M. O. Harhay¹, D. E. Schaubel¹, S. E. Kimmel¹, A. J. Stephens-Shields¹
¹Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, ²Department of Surgery, Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: The lung allocation system in the U.S. prioritizes lung transplant candidates based on estimated pre- and post-transplant survival. However, these models do not account…
2020 American Transplant Congress
Comparison of Outcomes between Patients Bridged to Heart Transplantation with ECMO versus Those Not Bridged with ECMO During the Years 1985 to 2019
D. J. Miklin¹, A. D. Salimbangon², G. S. Liu¹, P. Banankhah¹, P. A. Genyk¹, P. Kingsford¹, R. R. Chand³, J. P. Li¹, D. Vucicevic⁴, A. S. Vaidya¹, K. Pandya¹, J. Rahman¹, M. Fong¹, L. Grazette¹, A. Kiankhooy¹, J. Nattiv¹, S. Hashmi¹, S. Nuno¹, J. Pizula¹, A. E. Lee¹, K. Yang¹, S. Shaw¹, E. DePasquale¹, W. M. Aaron⁵
¹LAC-USC, Los Angeles, CA, ²UCLA Medical Center, Los Angeles, CA, ³Harbor-UCLA Medical Center, Los Angeles, CA, ⁴Newark Beth-Israel Medical Center, Newark, NJ, ⁵University of Arizona Sarver Heart Center, Tucson, AZ
*Purpose: Some patients with cardiogenic shock require extracorporeal membrane oxygenation (ECMO) for successful bridging to heart transplantation (HT). Herein, we report on the outcomes and…
2020 American Transplant Congress
Proposed New Pancreas Allocation Policy: Moving to Concentric Circles as First Unit of Allocation
A. Israni¹, S. Gustafson¹, B. Thompson¹, A. Wey¹, S. Niederhaus², R. Forbes³, A. Fox⁴, B. Kasiske¹, J. Snyder¹
¹SRTR, Minneapolis, MN, ²Univ of Maryland, Baltimore, MD, ³Vanderbilt Univ, Nashville, TN, ⁴UNOS, Richmond, VA
*Purpose: The Organ Procurement and Transplantation Network (OPTN) proposed a new national deceased donor pancreas allocation policy that removes donor service area and OPTN region…
2020 American Transplant Congress
Validation of the Model for End-Stage Liver Disease Sodium Score in the Eurotransplant Region
B. F. Goudsmit¹, H. Putter², B. Van Hoek³, A. E. Braat¹
¹Transplantation Surgery, Leiden University Medical Center, Leiden, Netherlands, ²Biostatistics, Leiden University Medical Center, Leiden, Netherlands, ³Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands
*Purpose: The shortage of liver grafts results in the prioritization of the sickest patients on the waiting list for liver transplantation. Since 2006, the degree…
2020 American Transplant Congress
Is Dual Allocation Successful at Higher Remuzzi Scores? Outcomes of Dual Kidney Transplants at Remuzzi Scores of 8 or Greater
V. Fleetwood¹, C. Kensinger², C. Papageorge¹, D. Aufhauser¹, G. Leverson³, B. Welch¹, D. Foley¹, P. Pasha¹
¹Department of Transplantation, University of Wisconsin, Madison, WI, ²Department of Transplantation, Piedmont Transplant Center, Atlanta, GA, ³Department of Statistics, University of Wisconsin, Madison, WI
*Purpose: The Remuzzi score (RS) is a histologic assessment of donor kidneys based on degree of glomerulosclerosis, arterial narrowing, interstitial fibrosis, and tubular atrophy. The…
2020 American Transplant Congress
The Trend of Non-Utilization and Decline of Hepatitis C Virus Antibody-Positive Deceased Donor Kidneys
S. Chang¹, K. Lentine², D. Axelrod³, J. Wellen¹, M. Wang¹, M. A. Schnitzler⁴, T. Alhamad⁵
¹Surgery, Washington University School of Medicine, Saint Louis, MO, ²Surgery, Saint Louis University, Saint Louis, MO, ³Surgery, University of Iowa, Iowa City, IA, ⁴Surgery, Sanit Louis University, Saint Louis, MO, ⁵Washington University School of Medicine, Saint Louis, MO
*Purpose: With more transplant centers are accepting hepatitis C virus infected (HCV+) deceased donor kidneys (dHCV+), the trend of non-utilization and decline of these organs…
2020 American Transplant Congress
Investigating the 6-Month Effects of the UNOS Allocation System Changes on the Post Transplant Outcomes in Patients with Hypertrophic Cardiomyopathy
P. Banankhah¹, C. Lum², A. Salimbangon³, G. Liu¹, A. Wolfson⁴, E. DePasquale¹, R. Chand⁵, P. Genyk¹, P. Kingsford¹, J. Li¹, D. Vucicevic⁶, A. Vaidya¹, K. Pandya¹, J. Rahman¹, M. Fong¹, L. Grazette¹, J. Nattiv¹, S. Hashmi¹, S. Nuno¹, J. Pizula¹, A. Lee¹, K. Yang¹, S. Shah¹
¹Cardiology, University of Southern California, Los Angeles, CA, ²The Queen's Medical Center, Honolulu, HI, ³Cardiology, UCLA Medical Center, Los Angeles, CA, ⁴University of Arizona Sarver Heart Center, Tucson, CA, ⁵Cardiology, Harbor-UCLA Medical Center, Los Angeles, CA, ⁶Cardiology, Newark Beth-Israel Medical Center, Newark, NJ
*Purpose: Hypertrophic cardiomyopathy (HCM) has a broad spectrum of presentations. However, the prognosis is poor in patients presenting with significant chamber remodeling, and they often…
2020 American Transplant Congress
Viremic Hepatitis C (HCV) Donors a Viable Option for Lung Transplant Recipients Treated with Real World Delayed Therapy
S. A. Kakoullis, E. M. Eichenberger, J. M. Steinbrink, E. Maziarz, H. Ali, H. Berry, J. Haney, J. Klapper, J. M. Reynolds, C. R. Wolfe
Duke University, Durham, NC
*Purpose: We present an IRB-approved trial of nucleic acid test (NAT) positive HCV donors (D+) used for HCV-negative recipients (R-) at Duke University for patients…
2020 American Transplant Congress
Simultaneous Heart Kidney Transplant Benefits are Concentrated in the Dialysis Dependent Population
B. I. Shaw¹, M. L. Samoylova¹, Z. W. Fitch¹, M. Bishawi¹, R. Schmitz¹, S. J. Kesseli¹, A. S. Barbas¹, C. B. Patel², S. L. Sanoff², L. M. McElroy¹
¹Surgery, Duke University, Durham, NC, ²Medicine, Duke University, Durham, NC
*Purpose: With ongoing growth of simultaneous organ transplant and increased attention to allocation policy, we examined trends in simultaneous heart-kidney (SHK) transplantation outcomes over the…